Winthrop P. Rockefeller Cancer Institute

August 19, 2021

UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana

David Robinson

Taren Swindle, Ph.D., here visiting a Head Start classroom in 2019, is leading the NCI-funded study that aims to improve diets in early care and education settings.

UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.

August 10, 2021

Samer Al Hadidi, M.D., Joins the UAMS Myeloma Center

Linda Haymes

Samer Al Hadidi, M.D.

LITTLE ROCK — Samer Al Hadidi, M.D., has joined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where he will treat patients with myeloma and other plasma cell disorders. “I’m very happy to welcome Dr. Al Hadidi to our staff,” said Frits van Rhee,…

August 9, 2021

UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients

Linda Haymes

“This offers an entirely new treatment option for relapsed myeloma patients,” said Myeloma Center clinical director Frits van Rhee, M.D., Ph.D. “It is a whole new class of treatment; it’s like immunotherapy is coming of age.”

The Myeloma Center at the UAMS Winthrop P. Rockefeller Cancer Institute is offering a new cutting-edge immunotherapy treatment for myeloma patients. The University of Arkansas for Medical Sciences (UAMS) is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.

July 22, 2021

UAMS Performs First GammaTile Brain Surgery in Arkansas

Spencer Watson

UAMS surgeons prepare to perform the first surgery in Arkansas using GammaTile Therapy or surgically targeted radiation therapy.

LITTLE ROCK — Radiation oncologist  Richard Crownover, M.D., Ph.D., and neurosurgeon Analiz Rodriguez, M.D., Ph.D., and their care team at the University of Arkansas for Medical Sciences (UAMS) have performed the state’s first application of GammaTile Therapy.

July 21, 2021

Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team

David Robinson

Members of the UAMS proteomics team are Alan Tackett, Ph.D. (center front), and (l-r) Stephanie Byrum, Ph.D., Rick Edmondson, Ph.D., Aaron Storey, Ph.D., and Samuel Mackintosh, Ph.D.

LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…

July 16, 2021

Michael Birrer, M.D., Ph.D., Invested in Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute

Benjamin Waldrum

UAMS Executive Vice Chancellor and College of Medicine Dean Susan Smyth, M.D., and UAMS Chancellor Cam Patterson, M.D., MBA, present Birrer (seated) with his commemorative medallion and inscribed wooden chair.

LITTLE ROCK — Michael Birrer, M.D., Ph.D., vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), was invested July 15 in the Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute. “Michael Birrer’s scholarly corpus is incredibly impressive, and the…

July 6, 2021

Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students

Marty Trieschmann

The NIH-funded Partners in Cancer Research Program is underway at the Winthrop P. Rockefeller Cancer Institute. Second-year medical students learning clinical and in-depth cancer research this summer include (l to r) Nadia Safar, Anna Bragg, Pamela Rosales, Payton Smith, Carl Ramponi, Faizan Cheema, Tom Kelly, M.D. (associate director of Cancer Research and Training), Angel Castro, Robert Kiss, Delanie Mack, Sangeetha Sonney and Claire Keisling. Matthew Newman is not pictured.

New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.  

June 24, 2021

UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer

David Robinson

UAMS' Hui-Ming Chang, M.D., is leading the Phoenix Trial.

LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…

June 21, 2021

‘Women Helping Women’ Art Donations Adorn Walls of Newly Opened UAMS Breast Center

Linda Haymes

Gwendolyn Bryant-Smith, M.D., director of the Breast Center at the Winthrop P. Rockefeller Cancer Institute and Natalie Rockefeller, who serves on the institute's board of directors, prepare to see "Hope Blooms" by local artist Morgan Coven Herndon hung as one of the first three of several works are displayed in the center.

The first piece that went up for sale one late afternoon in early April couldn’t have been more aptly named. “Hope Blooms,” shows a bouquet of colorful flowers, appearing to burst forth from a blue glass jar. Artist Morgan Coven Herndon’s 48 x 48-inch acrylic and latex on gallery-wrapped canvas was $850 plus tax. It…

June 1, 2021

Jenkins to Help Lead Clinical Trials Expansion at UAMS Winthrop P. Rockefeller Cancer Institute

Linda Haymes

Amy Jo Jenkins, M.S., CCRP, leads Early Phase Clinical Trials in the UAMS Winthrop P. Rockefeller Cancer Institute’s new Office of Clinical Trials Administration.

LITTLE ROCK — Amy Jo Jenkins, M.S., CCRP, recently joined the Winthrop P. Rockefeller Cancer Institute’s new Office of Clinical Trials Administration and will lead the Early Phase Clinical Trials at the University of Arkansas for Medical Sciences (UAMS).


Previous page Next page